Cargando…
Pathologic Response to Neoadjuvant Sequential Chemoradiation Therapy in Locally Advanced Breast Cancer: Preliminary, Translational Results from the French Neo-APBI-01 Trial
SIMPLE SUMMARY: Combined radiation therapy sequentially to neoadjuvant chemotherapy has been progressively assessed in breast cancer. The prediction of response to this innovative sequence is mandatory for treatment personalization. We conducted a translational study of the randomized phase 2 Neo-AP...
Autores principales: | To, Nhu Hanh, Gabelle-Flandin, Isabelle, Luong, Thi My Hanh, Loganadane, Gokoulakrichenane, Ouidir, Nabila, Boukhobza, Chahrazed, Grellier, Noémie, Verry, Camille, Thiolat, Allan, Cohen, José L., Radosevic-Robin, Nina, Belkacemi, Yazid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092968/ https://www.ncbi.nlm.nih.gov/pubmed/37046691 http://dx.doi.org/10.3390/cancers15072030 |
Ejemplares similares
-
Atypical responses to neoadjuvant chemotherapy combined with accelerated partial breast tumor-directed radiotherapy: two cases and considerations for future clinical trials
por: To, Nhu Hanh, et al.
Publicado: (2022) -
Interaction between Radiation Therapy and Targeted Therapies in HER2-Positive Breast Cancer: Literature Review, Levels of Evidence for Safety and Recommendations for Optimal Treatment Sequence
por: Debbi, Kamel, et al.
Publicado: (2023) -
Radiation Therapy Delivery Challenges in Older Patients During Coronavirus Disease 2019 Pandemic
por: Cherif, Mohamed Aziz, et al.
Publicado: (2020) -
Neoadjuvant radiotherapy in triple-negative breast cancer: “the past should not steal the present or hide the future”
por: To, Nhu Hanh, et al.
Publicado: (2022) -
Genomic Prostate Score: A New Tool to Assess Prognosis and Optimize Radiation Therapy Volumes and ADT in Intermediate-Risk Prostate Cancer
por: Belkacemi, Yazid, et al.
Publicado: (2023)